Skip to main content

ADHD Drug Zenzedi Recalled Over Pill Mixup

Medically reviewed by Judith Stewart, BPharm. Last updated on Jan 30, 2024.

By Robin Foster HealthDay Reporter

TUESDAY, Jan. 30, 2024 -- The maker of a drug used to treat ADHD and narcolepsy has recalled one lot of the medication after a pill mixup was discovered.

The recall notice, issued by Azurity Pharmaceuticals Inc., states that one lot of Zenzedi 30-milligram tablets is being recalled after a pharmacist found antihistamine tablets in a bottle labeled as Zenzedi.

The active compound in Zenzedi is dextroamphetamine sulfate, a stimulant used for the treatment of narcolepsy and ADHD. Meanwhile, the allergy drug found in the mislabeled bottles contains the sedative carbinoxamine, which has the opposite effect of a stimulant.

The recall comes amid an ongoing national shortage of ADHD drugs, creating further frustration for people with ADHD who have struggled to find medications for their condition, CNN reported.

The recall notice said that people who take carbinoxamine instead of Zenzedi have a higher risk of accidents or injuries and may have drowsiness, increased eye pressure, urinary obstruction and thyroid disorder. The recalled lot has the lot number F230169A and an expiration date of June 2025.

Azurity added that it has not received any reports of serious injury related to the medication mixup.

Consumers who have the recalled medication should return it to their pharmacy and call their doctor if they have any bad reactions to the drug.

Problems may also be reported to the FDA’s MedWatch Adverse Event Reporting program.

Sources

  • U.S. Food and Drug Administration, recall notice, Jan. 25, 2024

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted January 2024

Read this next

Staying Fit Boosts Kids' Mental Health

TUESDAY, April 30, 2024 -- The benefits of physical fitness for kids spill over into their mental health, new research shows. Getting plenty of exercise may guard against...

Opioids During Pregnancy May Not Raise Psychiatric Risks for Offspring

THURSDAY, April 24, 2024 -- Prescription opioids taken during pregnancy are not associated with a substantial increase in risk of developmental disorders like ADHD in children, a...

Acetaminophen Use During Pregnancy Poses No Risk of Autism, ADHD in Kids

TUESDAY, April 9, 2024 (HealthDay News) -- There’s no evidence that acetaminophen use during pregnancy increases the risk of childhood autism, ADHD or intellectual...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.